Community assessment of methods to deconvolve cellular composition from bulk gene expression
-
Published:2024-08-27
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
White Brian S.ORCID, de Reyniès Aurélien, Newman Aaron M.ORCID, Waterfall Joshua J.ORCID, Lamb Andrew, Petitprez FlorentORCID, Lin YatingORCID, Yu RongshanORCID, Guerrero-Gimenez Martin E., Domanskyi Sergii, Monaco GianniORCID, Chung VerenaORCID, Banerjee JinetaORCID, Derrick DanielORCID, Valdeolivas Alberto, Li Haojun, Xiao XuORCID, Wang ShunORCID, Zheng Frank, Yang WenxianORCID, Catania Carlos A., Lang Benjamin J.ORCID, Bertus Thomas J., Piermarocchi Carlo, Caruso Francesca P.ORCID, Ceccarelli MicheleORCID, Yu Thomas, Guo Xindi, Bletz Julie, Coller John, Maecker HoldenORCID, Duault CarolineORCID, Shokoohi Vida, Patel Shailja, Liliental Joanna E., Simon Stockard, , de Reyniès Aurélien, Saez-Rodriguez JulioORCID, Heiser Laura M.ORCID, Guinney Justin, Gentles Andrew J.ORCID
Abstract
AbstractWe evaluate deconvolution methods, which infer levels of immune infiltration from bulk expression of tumor samples, through a community-wide DREAM Challenge. We assess six published and 22 community-contributed methods using in vitro and in silico transcriptional profiles of admixed cancer and healthy immune cells. Several published methods predict most cell types well, though they either were not trained to evaluate all functional CD8+ T cell states or do so with low accuracy. Several community-contributed methods address this gap, including a deep learning-based approach, whose strong performance establishes the applicability of this paradigm to deconvolution. Despite being developed largely using immune cells from healthy tissues, deconvolution methods predict levels of tumor-derived immune cells well. Our admixed and purified transcriptional profiles will be a valuable resource for developing deconvolution methods, including in response to common challenges we observe across methods, such as sensitive identification of functional CD4+ T cell states.
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute U.S. Department of Health & Human Services | National Institutes of Health A.d.R was supported by the Programme Cartes d’Identité des Tumeurs (CIT) from the Ligue Nationale Contre le Cancer J.J.W. was supported by the SiRIC-Curie program F.P. was supported by the Programme Cartes d’Identité des Tumeurs (CIT) from the Ligue Nationale Contre le Cancer
Publisher
Springer Science and Business Media LLC
Reference90 articles.
1. Petitprez, F. et al. Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies. Cancer Immunol. Immunother. 67, 981–988 (2018). 2. Petitprez, F. et al. Quantitative analyses of the tumor microenvironment composition and orientation in the era of precision medicine. Front. Oncol.8, 390 (2018). 3. Lun, X.-K. & Bodenmiller, B. Profiling cell signaling networks at single-cell resolution. Mol. Cell. Proteom. 19, 744–756 (2020). 4. Goltsev, Y. et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174, 968–981.e15 (2018). 5. Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417–422 (2014).
|
|